RNXT
RenovoRx Inc
NASDAQ: RNXT · HEALTHCARE · BIOTECHNOLOGY
$0.85
+2.27% today
Updated 2026-04-30
Market cap
$37.84M
P/E ratio
—
P/S ratio
33.70x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$1 – $1
Volume
0.4M
RenovoRx Inc (RNXT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.35M | $-3.53M | $-5.92M | $-8.81M | $-10.26M | $-9.13M | $-10.97M |
| Capital expenditures | $15000.00 | $15000.00 | $15000.00 | $0.00 | $0.00 | $12000.00 | $2000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $38000.00 | $50000.00 | $147000.00 | $644000.00 | $1.08M | $1.17M | $1.27M |
| Free cash flow | $-3.37M | $-3.54M | $-5.93M | $-8.81M | $-10.26M | $-9.14M | $-10.97M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |